Smith, Michael A.
Chiang, Chia-Chien http://orcid.org/0000-0002-2110-8278
Zerrouki, Kamelia
Rahman, Saifur
White, Wendy I.
Streicher, Katie
Rees, William A.
Schiffenbauer, Adam
Rider, Lisa G.
Miller, Frederick W.
Manna, Zerai
Hasni, Sarfaraz
Kaplan, Mariana J. http://orcid.org/0000-0003-2968-0815
Siegel, Richard
Sinibaldi, Dominic
Sanjuan, Miguel A.
Casey, Kerry A. http://orcid.org/0000-0001-7194-8585
Funding for this research was provided by:
Funded by AstraZeneca
Article History
Received: 2 August 2019
Accepted: 13 February 2020
First Online: 10 March 2020
Competing interests
: M.A.Sm. and W.A.R. were employees of AstraZeneca at the time that this analysis was conducted, hold stock/shares in AstraZeneca PLC, and are currently employees of Viela Bio. S.H. was supported by the NIH/NIAMS during the conduct of the study and supported [in part] by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. C.C.C., K.Z., S.R., W.I.W., D.S., and K.S. are employees of AstraZeneca and hold stock/shares in AstraZeneca PLC. M.A.Sa. was an employee of AstraZeneca at the time that this analysis was conducted, holds stock/shares in AstraZeneca PLC, and is currently an employee of Bristol-Myers Squibb. M.J.K. was supported by the NIH/NIAMS during the conduct of the study. K.A.C. was an employee of AstraZeneca at the time that this analysis was conducted and is currently an employee of Bristol-Myers Squibb. R.S. reports intramural funding from National Institutes of Health (NIH) during the conduct of the study; and has been at Novartis Institutes of BioMedical Research since June 2018. A.S., L.G.R., F.W.M., and Z.M. have nothing to declare.